YORK, PA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)YORK OPIOID COLLABORATIVE, founded in 2017, is a small nonprofit in the Mental Health sector that reported $568K in total revenue in fiscal year 2023. Revenue surged 151% from the prior year, signaling strong growth momentum. The organization ran a surplus of $275K, a strong 48% operating margin.
TO COORDINATE AND CREATE COLLABORATIONS THAT RAISE AWARENESS AND ADVOCATE FOR SUPPORT TO COLLECTIVELY IMPLEMENT SOLUTIONS AND PROGRAMS FOR SUBSTANCE USE DISORDERS.
COMMUNITY EDUCATION/AWARENESS: THE YORK OPIOID COLLABORATIVE BRINGS PARTNERS TOGETHER TO INCREASE ITS DEPTH AND BREDTH OF CONNETIVITY IN THE COMMUNITY TO ESTABLISH A SHARED UNDERSTANDING, SHARED...
COMMUNITY EDUCATION/AWARENESS: THE YORK OPIOID COLLABORATIVE BRINGS PARTNERS TOGETHER TO INCREASE ITS DEPTH AND BREDTH OF CONNETIVITY IN THE COMMUNITY TO ESTABLISH A SHARED UNDERSTANDING, SHARED ACCOUNTABILITY AND OPTIMIZE CAPACITY TO RESPOND. EDUCATION/AWARENESS OF THE IMPACT OF SUBSTANCE USE SYSTEMICALLY TO OUR PARTNERS, AS WELL AS OPPORTUNITIES TO EDUCATE PUBLIC. ACTIVITIES UNDER THIS INCLUDE PHAST AND OFR.
STAKEHOLDER ENGAGEMENT / CAPACITY BUILDING: WORK WITH COMMUNITY PARTNERS TO IDENTIFY GAPS/OPPORTUNITIES TO RESPOND TO IMPACT OF SUBSTANCE USE. HELP BUILD CAPACITY FOR EVIDENCE BASED PRACTICES THROUGH...
STAKEHOLDER ENGAGEMENT / CAPACITY BUILDING: WORK WITH COMMUNITY PARTNERS TO IDENTIFY GAPS/OPPORTUNITIES TO RESPOND TO IMPACT OF SUBSTANCE USE. HELP BUILD CAPACITY FOR EVIDENCE BASED PRACTICES THROUGH FACILITATED DISCUSSIONS.
HARM REDUCTION ACTIVITIES: ACTIVITIES TO SUPPORT OVERDOSE PREVENTION STRATEGIES AND HARM REDUCTION STRATEGIES TO PROMOTE THE HEALTH, SAFETY AND WELL-BEING OF THOSE WITH A SUBSTANCE USE DISORDER...
HARM REDUCTION ACTIVITIES: ACTIVITIES TO SUPPORT OVERDOSE PREVENTION STRATEGIES AND HARM REDUCTION STRATEGIES TO PROMOTE THE HEALTH, SAFETY AND WELL-BEING OF THOSE WITH A SUBSTANCE USE DISORDER. RECEIVED GRANTS UNDER THIS ACTIVITY TO SUPPORT NALOXONE DISTRIBUTION AND MEDICATION COLLECTION/DISPOSAL OPTIONS INCLUDING SHARPS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $567,683 | $226,136 | +1.5% |
| Expenses | $292,503 | $184,283 | +0.6% |
| Net Income | $275,180 | $41,853 | +5.6% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| KYLE KING | CHAIRPERSON | 4.00 |
Officer
Director
|
$0 | $0 | $0 |
| MARGARET ECKLES-RAY | VICE CHAIRPERSON | 4.00 |
Officer
Director
|
$0 | $0 | $0 |
| SHANNON BRADY | SECRETARY | 4.00 |
Officer
Director
|
$0 | $0 | $0 |
| CHAD DEARDORFF | TREASURER | 4.00 |
Officer
Director
|
$0 | $0 | $0 |
| SUZANNE SCHLAGER | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| TANIA ZECH | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| LAUREN DAYS | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| REGINALD HUNTER | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| AUTHERINE SHAW | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| JACQUELYN KREISER | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| SAMANTHA ZAHM | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| ZACHARY CLAGHORN LEFT 0124 | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| TL KEARNEY STARTED 0124 | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| KAYLEE SWANSON | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| LAMAR STEVENS LEFT 0124 | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| BRITTANY SHUTZ | EXECUTIVE DIRECTOR | 40.00 |
Director
|
$57,730 | $11,965 | $69,695 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | No data | No data | No data | No data |
| 2024 | $567,683 | $292,503 | $598,406 | $275,180 |
| 2023 | $226,136 | $184,283 | $323,226 | $41,853 |
| 2022 | $132,134 | $189,809 | $281,373 | $-57,675 |
| 2021 | $272,853 | $131,806 | $339,048 | $141,047 |
| 2020 | $152,952 | $125,304 | $198,001 | $27,648 |
Compare YORK OPIOID COLLABORATIVE with other nonprofits in Pennsylvania and across the country.